Skip to main content
Novartis
language-selector-globe
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | English(link is external)
Novartis Foundation | English(link is external)
Argentina | Español(link is external)
Brazil | Português(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Mexico | Español(link is external)
United States | English(link is external)
Australia | English(link is external)
Bangladesh | English(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
India | English(link is external)
Indonesia | English(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Singapore | English(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Austria | Deutsch(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Bulgaria | Български(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hungary | Magyar(link is external)
Ireland | English(link is external)
Italy | Italiano(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Serbia | Srpski(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
Egypt | English(link is external)
Israel | עברית(link is external)
Saudi Arabia | العربية(link is external)
South Africa | English(link is external)
language-selector-globe
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español(link is external)
Australia | English(link is external)
Austria | Deutsch(link is external)
Bangladesh | English(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Brazil | Português(link is external)
Bulgaria | Български(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Egypt | English(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
Hungary | Magyar(link is external)
India | English(link is external)
Indonesia | English(link is external)
Ireland | English(link is external)
Israel | עברית(link is external)
Italy | Italiano(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Mexico | Español(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Saudi Arabia | العربية(link is external)
Serbia | Srpski(link is external)
Singapore | English(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
South Africa | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
United States | English(link is external)
    • About  (link is external)

      • Board of Directors  (link is external)

        • Giovanni Caforio  (link is external)
        • Simon Moroney  (link is external)
        • Ton Buechner  (link is external)
        • Patrice Bula  (link is external)
        • Elizabeth (Liz) Doherty  (link is external)
        • Ana de Pro Gonzalo  (link is external)
        • Bridgette Heller  (link is external)
        • Daniel Hochstrasser  (link is external)
        • Frans van Houten  (link is external)
        • Elizabeth McNally  (link is external)
        • John D. Young  (link is external)
        • Charlotte Pamer-Wieser  (link is external)
      • Executive Committee  (link is external)

        • Vasant (Vas) Narasimhan  (link is external)
        • Shreeram Aradhye  (link is external)
        • Victor Bulto  (link is external)
        • Aharon (Ronny) Gal  (link is external)
        • Karen L. Hale  (link is external)
        • Patrick Horber  (link is external)
        • Harry Kirsch  (link is external)
        • Rob Kowalski  (link is external)
        • Steffen Lang  (link is external)
        • Fiona Marshall  (link is external)
        • Lutz Hegemann  (link is external)
        • Kees Roks  (link is external)
        • Michelle Weese  (link is external)
      • Products  (link is external)
      • Therapeutic areas  (link is external)

        • Cardiovascular, renal and metabolic  (link is external)
        • Immunology  (link is external)
        • Neuroscience  (link is external)
        • Oncology  (link is external)
      • People and culture  (link is external)
      • Inclusion  (link is external)

        • Promoting inclusion  (link is external)
        • Building belonging  (link is external)
        • Parental leave  (link is external)
      • Novartis Gene Therapies  (link is external)
      • Manufacturing  (link is external)
      • Quality  (link is external)

        • Audit program  (link is external)
        • Novartis quality management system (QMS)  (link is external)
        • Product and patient safety training  (link is external)
        • Regulatory inspections  (link is external)
        • Product recalls  (link is external)
        • Third-party suppliers  (link is external)
      • Novartis and the European Union (EU)  (link is external)
      • Awards and recognition  (link is external)
      Mother and daughter cuddling on a bed in a kids room

      About

      Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

    • Patients and caregivers  (link is external)

      • Novartis commitment to patients and caregivers  (link is external)
      • Diseases  (link is external)
      • Patient organization funding  (link is external)
      • Patients perspectives stories  (link is external)
      Adult daughter talking to her senior parents on a bench in a park

      Patients and caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare professionals  (link is external)

      • Medical congresses and events  (link is external)

        • ASCO Annual Meeting  (link is external)
      • Products  (link is external)
      • Novartis pipeline  (link is external)
      • Managed access programs  (link is external)

        • Zolgensma® Global Managed Access Program (gMAP)  (link is external)
      • Novartis external funding  (link is external)
      • Healthcare professional resources by country  (link is external)
      • Investigator-initiated trials / studies  (link is external)
      • Novartis medical information  (link is external)

        • Submit medical enquiry  (link is external)
      Doctor discussing illness with patient in an office

      Healthcare professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research and development  (link is external)

      • Technology platforms  (link is external)
      • Research disease areas  (link is external)

        • Cardiovascular and metabolic disease research at Novartis  (link is external)
        • DAx: exploratory disease research at Novartis  (link is external)
        • Global Health disease area research at Novartis  (link is external)
        • Immunology disease research at Novartis  (link is external)
        • Neuroscience research at Novartis  (link is external)
        • Oncology research at Novartis  (link is external)
      • Novartis pipeline  (link is external)
      • Research collaborations  (link is external)
      • Collaborations  (link is external)
      A female research scientist in a lab looking at a sample

      Research & development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG  (link is external)

      • Access  (link is external)

        • Creating sustainable business models  (link is external)
        • Value-based pricing  (link is external)
        • Sub-Saharan Africa  (link is external)
        • Donations  (link is external)
        • Novartis access principles  (link is external)
        • Novartis oncology access  (link is external)
        • Patents and licensing  (link is external)
      • Environmental sustainability  (link is external)

        • Climate  (link is external)
        • Nature - Waste  (link is external)
        • Nature - Water  (link is external)
      • Ethics, risk and compliance  (link is external)

        • Ethical behavior  (link is external)
        • Compliance  (link is external)
        • Human rights  (link is external)
        • Learning and engagement  (link is external)
        • Integrated risk assurance  (link is external)
      • Global health  (link is external)

        • Pandemic preparedness  (link is external)
        • Avoidable blindness  (link is external)
        • Chagas disease  (link is external)
        • Leprosy  (link is external)
        • Malaria  (link is external)
        • Sickle cell disease (SCD)  (link is external)
        • Novartis Foundation  (link is external)
      • Inclusion  (link is external)
      • ESG index  (link is external)
      • Reporting and transparency hub  (link is external)

        • ESG rating performance  (link is external)
        • Targets  (link is external)
        • Patient organization funding  (link is external)
        • Payments to healthcare professionals  (link is external)
        • Public policy  (link is external)
        • A living wage  (link is external)
        • A safe workplace  (link is external)
        • Animal research  (link is external)
      Family and friends having a party at home

      Environmental, social and governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors  (link is external)

      • Event calendar  (link is external)
      • Financial data  (link is external)

        • Novartis annual results  (link is external)
        • Novartis quarterly results  (link is external)
        • Novartis SEC filings  (link is external)
        • Product sales  (link is external)
        • Fixed-income securities  (link is external)
        • Expected currency impact  (link is external)
      • Share data and analysis  (link is external)

        • Share monitor  (link is external)
        • Dividend information  (link is external)
        • Share ownership  (link is external)
        • Share overview  (link is external)
        • Return on investment calculator  (link is external)
      • Shareholder information  (link is external)

        • General Meetings  (link is external)
        • American Depositary Receipts (ADR)  (link is external)
        • Share buyback  (link is external)
        • Frequently asked questions  (link is external)
      • Company overview  (link is external)

        • Corporate governance  (link is external)
      • Reporting and transparency hub  (link is external)

        • Reporting archive  (link is external)
        • ESG rating performance  (link is external)
        • Publications order form  (link is external)
      • ESG  (link is external)
      Business woman working on her laptop in a bright atmosphere

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News  (link is external)

      • Newsroom  (link is external)
      • Media library   (link is external)
      • Stories  (link is external)
      • Subscribe  (link is external)
      • Events  (link is external)
      Overhead view of a meeting room with people in the foreground and screens in the background

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers  (link is external)

      • Career search  (link is external)
      • Our business functions  (link is external)

        • Careers in research and development  (link is external)
        • Careers in operations  (link is external)
        • Careers in commercial and sales  (link is external)
        • Careers in global functions  (link is external)
      • Why Novartis  (link is external)
      • Career hub  (link is external)

        • Temporary contracts  (link is external)
      • Early careers  (link is external)

        • Graduates  (link is external)
        • Students  (link is external)
        • US Biomedical Research internship programs  (link is external)
        • Community exploration and learning lab (CELL)  (link is external)
      Two business people

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical trials  (link is external)
    • Partnering  (link is external)
    • Supplier portal  (link is external)
    • Report side effects  (link is external)
    • Contacts  (link is external)
    Grandmother, mother and daughter smiling and laughing on a beach

    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

  1. Home(link is external)
  2. News(link is external)
  3. Media Library(link is external)
  4. Victor Bulto(link is external)

Victor Bulto

Back to previous page
Victor Bulto, President, US
Description

President, US

Usage Rights & Restrictions

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Download (IMAGE 804.28 KB) (link is external)

Related Items

  • Elizabeth McNally, M.D., Ph.D., Board member
    Image
    lock
    Leadership, Image
    Elizabeth McNally, M.D., Ph.D.
  • Giovanni Caforio, M.D., Board chair
    Image
    lock
    Leadership, Image
    Giovanni Caforio, M.D.
  • Patrick Horber, M.D. - President, International, since December, 2023
    Image
    lock
    Leadership, Image
    Patrick Horber, M.D.
  • Patrick Horber, M.D. - President, International, since December, 2023
    Image
    lock
    Leadership, Image
    Patrick Horber, M.D.

Novartis

Working together
  • Patients and caregivers(link is external)
  • Healthcare professionals(link is external)
  • Researchers(link is external)
  • Job seekers(link is external)
  • Journalists(link is external)
  • Investors(link is external)
Topics
  • Q1 2025(link is external)
  • Eurovision(link is external)
  • Access(link is external)
  • ESG(link is external)
  • SpeakUp(link is external)
Explore
  • Pipeline(link is external)
  • Products(link is external)
  • Clinical trials(link is external)
  • Partnering(link is external)
  • Events(link is external)
Therapeutic areas
  • Cardiovascular, renal and metabolic(link is external)
  • Immunology(link is external)
  • Neuroscience(link is external)
  • Oncology(link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis AG
  • Terms of use(link is external)
  • Privacy(link is external)
  • Cookie settings
  • Contacts(link is external)
  • Locations(link is external)
  • Site map(link is external)
  • Open source(link is external)
  • Web accessibility(link is external)
Novartis Site Directory (link is external)
This site is intended for a global audience